EL
EMMA LANGE
QUEST DIAGNOSTICS INCORPORATED · Secaucus, NJ · registered since 2024
Registered · LDAActive
At a glance
Registered since
2024
Senate LDA system
Clients
1
last 3 years
Filings
5
5 agencies contacted
Activity
filings by quarter
Works on
Specific issues
Federal policy and programs regarding oncology research and development related to cancer screening, diagnosis, and survivorship H.R. 9849 - Medical Laboratory Personnel Shortage Relief Act of 2024 H.R. 3248 - Diagnostic Lab Testing Transparency Act H.R. 5378 - Lower Costs, More Transparency Act H.R. 2369 - the Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2023 H.R. 88188 - American Privacy Rights Act of 2024 Food and Drug Administration (FDA) policies related to diagnostics and laboratory regulation CMS policies related to Medicare Advantage Engagement with executive branch departments/agencies regarding influenza A (H5) "Avian Flu"
P.L. 118-83/H.R. 9747- Continuing Appropriations and Extensions Act, 2025 , provisions related to Medicare reimbursement for clinical diagnostics laboratory services H.R. 2377/S. 1000 - Saving Access to Laboratory Services Act, provisions related to Medicare reimbursement for clinical diagnostics laboratory services P.L. 118-22/H.R. 6363 - Further Continuing Appropriations and Other Extensions Act, 2024 H.R. 4917 - Expanding Seniors Access to PFAS Testing Act H.R. 8702 - Improving Seniors Timely Access to Care Act H.R. 8839 - Maternal and Infant Syphilis Prevention Act Federal policy related to coverage and reimbursement of clinical laboratory services under the Medicare program
Federal policy and programs regarding oncology research and development related to cancer screening, diagnosis, and survivorship Federal policy related to strengthening the clinical laboratory workforce H.R. 3248 - Diagnostic Lab Testing Transparency Act H.R. 5378 - Lower Costs, More Transparency Act H.R. 2369 - the Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2023 Food and Drug Administration (FDA) policies related to diagnostics and laboratory regulation
P.L. 117-328/H.R. 2617- Consolidated Appropriations Act of 2023, provisions related to Medicare reimbursement for clinical diagnostics laboratory services H.R. 2377/S. 1000 - Saving Access to Laboratory Services Act, provisions related to Medicare reimbursement for clinical diagnostics laboratory services P.L. 118-22/H.R. 6363 - Further Continuing Appropriations and Other Extensions Act, 2024 H.R. 4917 - Expanding Seniors Access to PFAS Testing Act Federal policy related to coverage and reimbursement of clinical laboratory services under the Medicare program
Federal policy and programs regarding oncology research and development related to cancer screening, diagnosis, and survivorship Federal policy related to strengthening the clinical laboratory workforce H.R. 3248 - Diagnostic Lab Testing Transparency Act H.R. 5378 - Lower Costs, More Transparency Act H.R. 2369 - the Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2023 H.R. 88188 - American Privacy Rights Act of 2024 Food and Drug Administration (FDA) policies related to diagnostics and laboratory regulation CMS policies related to Medicare Advantage Engagement with executive branch departments/agencies regarding influenza A (H5) "Avian Flu"
P.L. 117-328/H.R. 2617- Consolidated Appropriations Act of 2023, provisions related to Medicare reimbursement for clinical diagnostics laboratory services H.R. 2377/S. 1000 - Saving Access to Laboratory Services Act, provisions related to Medicare reimbursement for clinical diagnostics laboratory services P.L. 118-22/H.R. 6363 - Further Continuing Appropriations and Other Extensions Act, 2024 H.R. 4917 - Expanding Seniors Access to PFAS Testing Act H.R. 8702 - Improving Seniors Timely Access to Care Act Federal policy related to coverage and reimbursement of clinical laboratory services under the Medicare program